Edwin Zhang
Stock Analyst at HC Wainwright & Co.
(n/a)
# 4,337
Out of 4,682 analysts
5
Total ratings
n/a
Success rate
-65.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edwin Zhang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Initiates: Buy | $106 | $46.67 | +127.13% | 1 | Sep 30, 2021 | |
| LOGC ContextLogic | Initiates: Buy | $15 | $7.58 | +97.89% | 1 | Jun 7, 2021 | |
| FGEN FibroGen | Downgrades: Neutral | n/a | $0.41 | - | 2 | Apr 7, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $26 | $4.74 | +448.52% | 1 | Feb 8, 2021 |
Ultragenyx Pharmaceutical
Sep 30, 2021
Initiates: Buy
Price Target: $106
Current: $46.67
Upside: +127.13%
ContextLogic
Jun 7, 2021
Initiates: Buy
Price Target: $15
Current: $7.58
Upside: +97.89%
FibroGen
Apr 7, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.41
Upside: -
Aldeyra Therapeutics
Feb 8, 2021
Initiates: Buy
Price Target: $26
Current: $4.74
Upside: +448.52%